Single Pulse Nanosecond Laser‐Stimulated Targeted Delivery of Anti‐Cancer Drugs from Hybrid Lipid Nanoparticles Containing 5 nm Gold Nanoparticles
Small · 2023
DOI: 10.1002/smll.202305591 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, 2023. Verfasst von Antoine Uzel und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Engineering Physics, Polytechnique Montréal, Montreal, QC, H3C 3A7, Canada. Hauptthemen laut MEDLINE: Metal Nanoparticles, Antineoplastic Agents, Nanoparticles. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NanoMedicines Innovation Network.
Abstract (Originalsprache)
Encapsulating chemotherapeutic drugs like doxorubicin (DOX) inside lipid nanoparticles (LNPs) can overcome their acute, systematic toxicity. However, a precise drug release at the tumor microenvironment for improving the maximum tolerated dose and reducing side effects has yet to be well‐established by implementing a safe stimuli‐responsive strategy. This study proposes an integrated nanoscale perforation to trigger DOX release from hybrid plasmonic multilamellar LNPs composed of 5 nm gold (Au) NPs clustered at the internal lamellae interfaces. To promote site‐specific DOX release, a single pulse irradiation strategy is developed by taking advantage of the resonant interaction between nanosecond pulsed laser radiation (527 nm) and the plasmon mode of the hybrid nanocarriers. This approach enlarges the amount of DOX in the target cells up to 11‐fold compared to conventional DOX‐loaded LNPs, leading to significant cancer cell death. The simulation of the pulsed laser interactions of the hybrid nanocarriers suggests a release mechanism mediated by either explosive vaporization of thin water layers adjacent to AuNP clusters or thermo‐mechanical decomposition of overheated lipid layers. This simulation indicates an intact DOX integrity following irradiation since the temperature distribution is highly localized around AuNP clusters and highlights a controlled light‐triggered drug delivery system.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Engineering Physics, Polytechnique Montréal, Montreal, QC, H3C 3A7, Canada.
- Department of Biochemistry and Molecular Biology, University of British Columbia, 2350 Health Sciences Mall, Vancouver, BC, V6T 1Z3, Canada.
ORCID-Profile: Leonidas Agiotis, Morteza Hasanzadeh Kafshgari, Michel Meunier
Förderung
- NanoMedicines Innovation Network
Zitieren
APA
Uzel, A., Agiotis, L., Baron, A., Zhigaltsev, I. V., Cullis, P. R., Hasanzadeh Kafshgari, M., & Meunier, M. (2023). Single Pulse Nanosecond Laser‐Stimulated Targeted Delivery of Anti‐Cancer Drugs from Hybrid Lipid Nanoparticles Containing 5 nm Gold Nanoparticles. Small. https://doi.org/10.1002/smll.202305591
Vancouver
Uzel A, Agiotis L, Baron A, Zhigaltsev IV, Cullis PR, Hasanzadeh Kafshgari M, et al. Single Pulse Nanosecond Laser‐Stimulated Targeted Delivery of Anti‐Cancer Drugs from Hybrid Lipid Nanoparticles Containing 5 nm Gold Nanoparticles. Small. 2023. doi:10.1002/smll.202305591
BibTeX
@article{Uzel2023,
author = {Uzel, Antoine and Agiotis, Leonidas and Baron, Amélie and Zhigaltsev, Igor V and Cullis, Pieter R and Hasanzadeh Kafshgari, Morteza and Meunier, Michel},
title = {Single Pulse Nanosecond Laser‐Stimulated Targeted Delivery of Anti‐Cancer Drugs from Hybrid Lipid Nanoparticles Containing 5 nm Gold Nanoparticles},
journal = {Small},
year = {2023},
doi = {10.1002/smll.202305591}
}
EUVIMED